PER percheron therapeutics limited

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-200

  1. 36 Posts.
    lightbulb Created with Sketch. 14

    Do I recall you mentioning after you attended the AGM, Gil Price by memory you were speaking to? He mentioned the Ph2a trial kids were still on other medications? Could it still be the case that avicursen works in conjunction with other medications only and not on its own? This theory would make sense to why they terminated the trial as they couldn't just start putting other drugs in arms 6 months into a trial to boost efficiency numbers.

    Forgive me clutching at straws
    Forgive my lack of time to be able to find your comment a few months ago.

    I look forward to the learnings I will gain when we all figure out (if we even do) how this mess come about.
    Definitely a massive investing lesson here for me.

    The binge was heavy this new years

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $7.665K 766.5K

Buyers (Bids)

No. Vol. Price($)
1 3790595 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3172198 6
View Market Depth
Last trade - 12.55pm 24/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.